Agnieszka Jagiello-Gruszfeld

Narodowy Instytut Onkologii im Marii Skłodowskiej-Curie Państwowy Instytut Badawczy w Warszawie

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (8)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (8)

Malgorzata Debowska

Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences

POLAND

View details

Olga Kuczkiewicz-Siemion

Institute of Hematology and Transfusion Medicine

POLAND

View details

Dorota Nowakowska

POLAND

View details

Renata Duchnowska

Prof.

Wojskowy Instytut Medyczny

POLAND

View details

Anna Niwinska

Prof.

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Anna Bednarek

Medical University of Silesia School of Medicine in Katowice

POLAND

View details

Janusz Siedlecki

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Magdalena Rosińska

current position: Head of Department

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Agnieszka Jagiello-Gruszfeld

Research Interests

Explore related searches

Contact this professor

Articles (8)

PD-L1-Positive High-Grade Triple-Negative Breast Cancer Patients Respond Better to Standard Neoadjuvant Treatment—A Retrospective Study of PD-L1 Expression in Relation to Different Clinicopathological Parameters

The Impact of Dietary Counselling on Achieving or Maintaining Normal Nutritional Status in Patients with Early and Locally Advanced Breast Cancer Undergoing Perioperative Chemotherapy

Intracranial Response Rate in Patients with Breast Cancer Brain Metastases after Systemic Therapy

Neoadjuvant Pertuzumab Plus Trastuzumab in Combination with Docetaxel and Carboplatin in Patients with HER2-Positive Breast Cancer: Real-World Data from the National Institute of Oncology in Poland

Health-related quality of life in older patients with HER2+ metastatic breast cancer: Comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trial

Alpelisib After Treatment with CDK4/6i and Aromatase Inhibitor: Case Report

Effects of BRCA Germline Mutations on Triple-Negative Breast Cancer Prognosis

Limitations of Systemic Oncological Therapy in Breast Cancer Patients with Chronic Kidney Disease

Collaborators (8)

Malgorzata Debowska

Olga Kuczkiewicz-Siemion

Dorota Nowakowska

Renata Duchnowska

Anna Niwinska

Anna Bednarek

Janusz Siedlecki

Magdalena Rosińska

Make your next move.